Navigation Links
UCSB scientists compile first study of potential for tsunamis in northwestern California
Date:6/27/2012

(Santa Barbara, Calif.) Using studies that span the last three decades, scientists at UC Santa Barbara have compiled the first evidence-based comprehensive study of the potential for tsunamis in Northwestern California. The paper, "Paleoseismicity of the Southern End of the Cascadia Subduction Zone, Northwestern California," was co-written by professors Edward Keller and Alexander Simms from UCSB's Department of Earth Science, and published in a recent issue of the Bulletin of the Seismological Society of America.

The paper is based on the Ph.D. dissertation of David Valentine, a research programmer at the Spatial Information Systems Laboratory at UC San Diego. Valentine, Keller's former student, completed his doctorate at UCSB in 2002 and is first author of the paper.

The region has long been known to experience large earthquakes, and scientific studies of seismic activity in the southern end of the Cascadia Subduction Zone (CSZ) which stretches northward from the area of Mendocino, Calif. have previously appeared in grey literature and in guidebooks. However, comprehensive, reviewed evidence-based work has been lacking, according to Keller.

"Science goes on evidence," he said, adding that in light of the recent earthquakes in Japan and Chile, the study of the same potential closer to home is "timely." The authors studied sedimentation patterns in salt marshes, floodplains, and estuaries in the northwestern corner of California for signs of seismic events that could lead to tsunami activity. They combined this with information gathered from numerous studies conducted over nearly 30 years by researchers at Humboldt State University

During an earthquake, the researchers say, there is a tendency for the coastal wetlands to become submerged, with coastal sediments depositing over plants and animals that live there. These become a fossilized record of sea-level change in the area.

The process has preserved a se
'/>"/>

Contact: Sonia Fernandez
sonia.fernandez@ia.ucsb.edu
805-893-4765
University of California - Santa Barbara
Source:Eurekalert

Page: 1 2

Related biology news :

1. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
2. Queens scientists seek vaccine for Pseudomonas infection
3. Scientists produce eye structures from human blood-derived stem cells
4. American Society of Plant Biologists honors early career women scientists
5. Brandeis scientists win prestigious prize for circadian rhythms research
6. Scientists discover new method of proton transfer
7. Salk scientists open new window into how cancers override cellular growth controls
8. WileyChina.com - Now Featuring Bespoke Pages for China’s Life Scientists
9. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
10. UGA scientists reveal genetic mutation depicted in van Goghs sunflower paintings
11. Genetic mutation depicted in van Goghs sunflower paintings revealed by scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... MINNEAPOLIS/ST. PAUL (MAY 20, 2013) University of Minnesota ... of Minnesota, in partnership with the University,s Brain Tumor ... peripheral nerve sheath tumors (MPNST) that allow them to ... of cancer. , The research was published this week ... the Sleeping Beauty transposon method, researchers in the lab ...
(Date:5/20/2013)... grant will help establish the Center for Advanced Research ... of Illinois at Urbana-Champaign and Worcester Polytechnic Institute (WPI) ... research in drying moist, porous materials such as food ... products; textiles; and biopharmaceuticals," said Hao Feng, a U ... and the Illinois site director. , According to Feng, ...
(Date:5/19/2013)... reports that white men and women of European descent ... and lesser toe deformities, including hammer or claw toe. ... the heritability of foot disorders in humansappear in ... Wiley on behalf of the American College of Rheumatology ... as 60% of older adults have foot disorders which ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2NSF approves planning grant for Center for Advanced Research in Drying 2Blame your parents for bunion woes 2
... available in Chinese on EurekAlert! Chinese . ... led by the University of Melbourne and BGI, has sequenced ... pig. This collaborative study, published online in the international journal ... community and paves the way for the development of new ...
... from VTT Technical Research Centre of Finland suggests ... microbial diversity of the Clostridium leptum subgroup, elevated ... In collaboration with the DIPP - Finnish Type ... previously found that specific metabolic disturbances precede early ...
... in German . The ability to dream ... images and emotions that we experience so intensively when we dream ... has not been possible to measure dream content. Max Planck scientists ... succeeded, for the first time, in analysing the activity of the ...
Cached Biology News:BGI reports pig parasite's genomic sequence provides new clues for parasitic diseases research 2VTT identified specific bacteria which precede autoimmune diabetes 2Scientists measure dream content for the first time 2
(Date:5/22/2013)... 22, 2013 Alton Housing Authority was hit ... 2013 said that their presence has already caused the ... sufferers avoid such big spending, My Cleaning Products shared a ... It was said in the report that to clear the ... Apart from that, its employees also attended a mandatory training ...
(Date:5/22/2013)...  Moderna Therapeutics, the pioneering company developing messenger RNA ... in vivo production of therapeutic proteins, announced ... join Moderna in early July as its first Chief ... leader in the design and implementation of information systems ... translation, clinical operations and commercial preparedness. John has also ...
(Date:5/21/2013)... Belmont, MA (PRWEB) May 21, 2013 ... complete tracking to reporting eLearning solution using Tin ... report and dashboard tool. CLD is a leading ... biotech, and medical device companies worldwide. , ... tracking standard that helps learners and trainers more ...
(Date:5/21/2013)... 2013 The congress of the ... is the biggest congress in Europe ... participants are in Istanbul to ... New pioneering studies have been presented: / ... ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" By ...
Breaking Biology Technology:Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3
... 2009 Highlights:- GAAP diluted EPS increased 16.0 percent ... EPS, excluding $0.05 in amortization of intangible assets ... $0.63 from $0.55 in first-quarter 2008- Total net ... billion- Specialty pharmacy revenues increased 21.0 percent to ...
... - Increases Accessibility to ... Elsevier, the world,s leading publisher of scientific, technical, ... ten new eBook,Specialty Collections have launched on MD ... This launch provides online availability,of market-leading specialty content ...
... experts listed in the Trusted LASIK Surgeons directory ... at the recently concluded American Society of Cataract ... San Francisco, California. Dr. Randy Epstein, Dr. ... Dr. R. Wayne Bowman, Dr. Shachar Tauber, and ...
Cached Biology Technology:Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 2Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 3Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 4Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 5Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 6Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 7Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 8Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 9Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 10Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 11Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 12Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 13Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 14Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 15Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 16Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 17Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 18Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 19Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 20Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 21Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 22Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 23Elsevier Launches Ten New eBook Specialty Collections on MD Consult 2Elsevier Launches Ten New eBook Specialty Collections on MD Consult 3Leading Refractive Eye Surgery Experts from Trusted LASIK Surgeons Directory Educate Peers at ASCRS Annual Meeting 2Leading Refractive Eye Surgery Experts from Trusted LASIK Surgeons Directory Educate Peers at ASCRS Annual Meeting 3Leading Refractive Eye Surgery Experts from Trusted LASIK Surgeons Directory Educate Peers at ASCRS Annual Meeting 4Leading Refractive Eye Surgery Experts from Trusted LASIK Surgeons Directory Educate Peers at ASCRS Annual Meeting 5Leading Refractive Eye Surgery Experts from Trusted LASIK Surgeons Directory Educate Peers at ASCRS Annual Meeting 6Leading Refractive Eye Surgery Experts from Trusted LASIK Surgeons Directory Educate Peers at ASCRS Annual Meeting 7Leading Refractive Eye Surgery Experts from Trusted LASIK Surgeons Directory Educate Peers at ASCRS Annual Meeting 8
... Factor XIII in both reduced and non-reduced ... XIII B-chain or human Factor XII. Factor XIII ... composed of two subunits. Factor XIII-A is the ... 160kDa. Factor XIII is present in plasma as ...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
Ca2+ Channel Ca gamma 2 Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 50 µl Consult technical datasheet for details....
Goat polyclonal to Centaurin alpha 2**...
Biology Products: